Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
It is backed by a caution inactive ingredient profile
It acts on GLP-1, GIP, and glucagon receptors, which are involved in appetite, glucose handling, and energy balance
TRIUMPH-4 (28.7% weight loss, knee OA population, December 2025), TRIUMPH-1 (28.3%, general obesity, May 2026), TRANSCEND-T2D-1 (-2.0% HbA1c, 16.8% weight loss, June 2026), TRIUMPH-2 (20.8% weight loss, obesity + diabetes, July 23, 2026), and TRIUMPH-3 (22.6% weight loss, obesity + cardiovascular disease, July 23, 2026) have all reported positive results
What not to eat on retatrutide
US$ 22.55
US$ 28.72
US$ 21.52
